Skip to main content
 

Aventyn

Aventyn

Aventyn is an innovative, award winning digital therapeutics company connecting patients and clinicians for precision chronic disease management. Vitalbeat connected wearables enable first-in-class, evidenced intelligent digital therapeutic actionable biomarkers for heart failure and co-morbidities. Vitalbeat clinically-validated solutions offer personalized, predictive health risk assessment and immersive virtual care delivery platform with integrated long haul disease management for improved patient health outcomes at lower cost and better quality of life.

More News

  • AccurKardia Secures FDA 510(k) Clearance of and Launches AccurECG 2.0

  • Amplity joins Innovators’ Network at the American Heart Association’s Center for Health Technology & Innovation

  • Smarter Care or Risky Business? Evaluating AI in Health Care